Inspire Veterinary Partners Files 8-K with Corporate Updates

TL;DR

Inspire Vet Partners filed an 8-K on Jan 23rd for events on Jan 22nd - expect corporate updates.

AI Summary

Inspire Veterinary Partners, Inc. filed an 8-K on January 23, 2025, reporting events as of January 22, 2025. The filing indicates amendments to articles of incorporation or bylaws, a Regulation FD disclosure, and the filing of financial statements and exhibits. The company is incorporated in Nevada and its principal executive offices are located in Virginia Beach, VA.

Why It Matters

This 8-K filing signals potential changes in Inspire Veterinary Partners' corporate structure or governance, which could impact its operational direction and investor relations.

Risk Assessment

Risk Level: low — The filing is a standard 8-K for corporate updates and does not appear to contain immediate negative financial news.

Key Players & Entities

• INSPIRE VETERINARY PARTNERS, INC. (company) — Registrant
• January 22, 2025 (date) — Date of earliest event reported
• January 23, 2025 (date) — Filing date
• Nevada (jurisdiction) — State of incorporation
• Virginia Beach, VA (location) — Address of principal executive offices

FAQ

Key Financial Figures

• $0.0001 — ch registered Common stock, par value $0.0001 IVP Nasdaq Capital Market Indicat

Filing Documents

• ea0228453-8k_inspire.htm (8-K) — 33KB
• ea022845301ex99-1_inspire.htm (EX-99.1) — 11KB
• ex99-1_001.jpg (GRAPHIC) — 17KB
• 0001213900-25-005649.txt ( ) — 244KB
• ivp-20250122.xsd (EX-101.SCH) — 3KB
• ivp-20250122_lab.xml (EX-101.LAB) — 33KB
• ivp-20250122_pre.xml (EX-101.PRE) — 22KB
• ea0228453-8k_inspire_htm.xml (XML) — 4KB

03 Amendments

Item 5.03 Amendments to the Articles of Incorporation or Bylaws; Change in Fiscal Year. As previously disclosed in a Current Report on Form 8-K filed on January 10, 2025, Inspire Veterinary Partners, Inc., a Nevada corporation, (the "Company") seeks to effect a one-for-twenty-five (1:25) reverse stock split (the " Reverse Stock Split") of its issued and outstanding shares of Class A common stock, $0.0001 par value per share ("Common Stock"). The Reverse Stock Split will become effective on January 27, 2025. The Common Stock will continue to be traded on The Nasdaq Capital Market under the symbol "IVP". Pursuant to the Reverse Stock Split, every twenty-five (25) outstanding shares of the Company's Common Stock will, without any further action by the Company, or any holder thereof, convert into, and automatically became, one (1) share of the Company's Common Stock. No fractional shares will be issued in connection with the Reverse Stock Split. All fractional shares will be rounded up. The Company has filed a Certificate of Change to the Company's Amended and Restated Certificate of Incorporation, as previously amended, with the Secretary of State of the State of Nevada. As a result of the filing of the Certificate of Change, and the resulting effectiveness of the Reverse Stock Split, the 36,998,148 shares of the Company's Common Stock issued and outstanding immediately prior to the Reverse Stock Split are being converted into approximately 1,479,926 shares of the Company's Common Stock. The total number of shares of Common Stock authorized for issuance will then be reduced by a corresponding proportion. Except for de minimis adjustments that result from the treatment of fractional shares, the Reverse Stock Split does not have any immediate dilutive effect on our stockholders, since each stockholders holds the same percentage of our Common Stock outstanding immediately following the Reverse Stock Split as such stockholder held immediately prior to the Reverse Stoc

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure. On January 22, 2025, the Company issued a press release announcing the Reverse Stock Split. A copy of the press release is furnished as Exhibit 99.1 hereto and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act, as amended ("Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Exchange Act or the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing with the Securities and Exchange Commission. Item9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press Release issued by Inspire Veterinary Partners, Inc. dated January 22, 2025 104 Cover Page Interactive Data File, formatted in Inline XBRL 1

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: January 22, 2025 INSPIRE VETERINARY PARTNERS, INC. By: /s/ Kimball Carr Name: Kimball Carr Title: President and Chief Executive Officer 2

View Full Filing

View this 8-K filing on SEC EDGAR